X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 18.0 36.3 49.7% View Chart
P/BV x 4.6 9.4 49.3% View Chart
Dividend Yield % 0.6 0.7 85.3%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ABBOTT INDIA
Mar-18
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6636,110 10.9%   
Low Rs3993,996 10.0%   
Sales per share (Unadj.) Rs535.61,552.2 34.5%  
Earnings per share (Unadj.) Rs15.9188.8 8.4%  
Cash flow per share (Unadj.) Rs20.0196.4 10.2%  
Dividends per share (Unadj.) Rs4.0055.00 7.3%  
Dividend yield (eoy) %0.81.1 69.2%  
Book value per share (Unadj.) Rs137.6796.6 17.3%  
Shares outstanding (eoy) m7.7721.25 36.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.3 30.5%   
Avg P/E ratio x33.326.8 124.5%  
P/CF ratio (eoy) x26.525.7 103.1%  
Price / Book Value ratio x3.96.3 60.9%  
Dividend payout %25.129.1 86.1%   
Avg Mkt Cap Rs m4,127107,376 3.8%   
No. of employees `0001.73.3 51.4%   
Total wages/salary Rs m6073,937 15.4%   
Avg. sales/employee Rs Th2,436.79,929.3 24.5%   
Avg. wages/employee Rs Th355.21,185.1 30.0%   
Avg. net profit/employee Rs Th72.51,207.7 6.0%   
INCOME DATA
Net Sales Rs m4,16232,985 12.6%  
Other income Rs m611,170 5.2%   
Total revenues Rs m4,22334,155 12.4%   
Gross profit Rs m1975,245 3.8%  
Depreciation Rs m32162 19.6%   
Interest Rs m3038 78.3%   
Profit before tax Rs m1976,215 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m732,203 3.3%   
Profit after tax Rs m1244,012 3.1%  
Gross profit margin %4.715.9 29.8%  
Effective tax rate %37.035.4 104.4%   
Net profit margin %3.012.2 24.5%  
BALANCE SHEET DATA
Current assets Rs m1,62922,655 7.2%   
Current liabilities Rs m1,0586,681 15.8%   
Net working cap to sales %13.748.4 28.3%  
Current ratio x1.53.4 45.4%  
Inventory Days Days3065 46.0%  
Debtors Days Days3429 115.2%  
Net fixed assets Rs m556835 66.6%   
Share capital Rs m78213 36.6%   
"Free" reserves Rs m87816,715 5.3%   
Net worth Rs m1,06916,928 6.3%   
Long term debt Rs m1590-   
Total assets Rs m2,39924,162 9.9%  
Interest coverage x7.6163.7 4.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.4 127.1%   
Return on assets %6.416.8 38.2%  
Return on equity %11.623.7 48.9%  
Return on capital %18.536.9 50.0%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m33369 8.9%   
Fx outflow Rs m633,807 1.7%   
Net fx Rs m-30-3,438 0.9%   
CASH FLOW
From Operations Rs m1271,527 8.3%  
From Investments Rs m-146-2,148 6.8%  
From Financial Activity Rs m22-1,024 -2.1%  
Net Cashflow Rs m3-1,646 -0.2%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SANOFI INDIA  ASTRAZENECA PHARMA  STRIDES PHARMA SCIENCE  STERLING BIOTECH  JUBILANT LIFE SCIENCES  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Where Will the Two-Faced Market Go from Here?(Podcast)

The stock markets are very volatile these days. As the Tanushree Bannerjee, the co-head of research here at Equitymaster puts it, stock markets are two-faced.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

Feb 4, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

Here's What the Biggest 'Rebirth of India' Investors are Doing(The 5 Minute Wrapup)

Feb 5, 2019

A roundtable on the 18th of January 2019 had investors with billions of dollars of investment kitty.

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Do You Have the Stomach to Survive a Small Cap Crash?(Profit Hunter)

Feb 5, 2019

While selecting good businesses is relatively easy task in a bearish phase, where most people fail is in having enough patience to hold the quality stocks until recovery.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 15, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS